ResTORbio Competitors and Similar CompaniesClear all
ResTORbio's competitors and similar companies include Protalex and Cygnal Therapeutics.
 ResTORbio ResTORbio is a company, developing medicines to treat aging-related diseases and conditions. |  Protalex Protalex is a clinical-stage biopharmaceutical company focused on the development of a class of drugs for treating autoimmune and inflammatory diseases. |  Cygnal Therapeutics Cygnal Therapeutics is a company developing drugs in the field of exoneural biology. | |
Founding Date | Founding Date 2016 | Founding Date 1999 | Founding Date 2017 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Boston, US HQ | Locations Florham Park, US HQ | Locations Cambridge, US HQ |
Employees | Employees 7 | Employees 233% decrease | Employees 11 |
Valuation ($) | Valuation ($) 11.9 m | Valuation ($) 615.2 k | Valuation ($) N/A |
Financial | |||
Net income | Net income ($62m) (FY, 2021) | Net income ($5m) (FY, 2018) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 65m | Total funding raised N/A | Total funding raised $ 65m |
For sources of this data, please see the company profile
View Company Profiles
Protalex
HQ
Florham Park, US
Employees
2↓ 33% decrease
Protalex is a clinical-stage biopharmaceutical company focused on the development of a class of drugs for treating autoimmune and inflammatory diseases.
View companyCygnal Therapeutics
HQ
Cambridge, US
Cygnal Therapeutics is a company developing drugs in the field of exoneural biology.
View company